Easy Access and Express Report Delivery Service
Brand Drugs Market, Global Outlook and Forecast 2024-2030
Report ID
46942
Publisher
Market Monitor Global
Published Date
07-Feb
Delivery Format
PDF
No of Report Page
158
Editor's Rating
-
Report Details
This research report provides a comprehensive analysis of the Brand Drugs market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Brand Drugs market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Brand Drugs, challenges faced by the industry, and potential opportunities for market players. The global Brand Drugs market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Brand Drugs market presents opportunities for various stakeholders, including Hospital, Clinic. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Brand Drugs market. Additionally, the growing consumer demand present avenues for market expansion. The global Brand Drugs market was valued at US$ 1010150 million in 2023 and is projected to reach US$ 1442970 million by 2030, at a CAGR of 5.3% during the forecast period. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs. Key Features: The research report on the Brand Drugs market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders. Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Brand Drugs market. Market Overview: The report provides a comprehensive overview of the Brand Drugs market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Biopharmaceutical, Chemistry Medicine), region, and application, highlighting the key drivers, challenges, and opportunities within each segment. Market Dynamics: The report analyses the market dynamics driving the growth and development of the Brand Drugs market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Brand Drugs market's trajectory. Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Brand Drugs market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments. Market Segmentation and Forecast: The report segment the Brand Drugs market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions. Technological Trends: The report should highlight the key technological trends shaping the Brand Drugs market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences. Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Brand Drugs market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders. Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Brand Drugs, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments. Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Brand Drugs market. Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts. Market Segmentation Brand Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value. Market segment by Type Biopharmaceutical Chemistry Medicine Market segment by Application Hospital Clinic Other Global Brand Drugs Market Segment Percentages, By Region and Country, 2023 (%) North America US Canada Mexico Europe Germany France U.K. Italy Russia Nordic Countries Benelux Rest of Europe Asia China Japan South Korea Southeast Asia India Rest of Asia South America Brazil Argentina Rest of South America Middle East & Africa Turkey Israel Saudi Arabia UAE Rest of Middle East & Africa Major players covered Pfizer Roche Sanofi Johnson & Johnson Merck & Co. (MSD) Novartis AbbVie Gilead Sciences GlaxoSmithKline (GSK) Amgen AstraZeneca Bristol-Myers Squibb Eli Lilly Teva Bayer Novo Nordisk AbbVie Takeda Boehringer Ingelheim Takeda Outline of Major Chapters: Chapter 1: Introduces the definition of Brand Drugs, market overview. Chapter 2: Global Brand Drugs market size in revenue. Chapter 3: Detailed analysis of Brand Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc. Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments. Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets. Chapter 6: Sales of Brand Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world. Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc. Chapter 8: The main points and conclusions of the report. -
Table Of Content
1 Introduction to Research & Analysis Reports 1.1 Brand Drugs Market Definition 1.2 Market Segments 1.2.1 Market by Type 1.2.2 Market by Application 1.3 Global Brand Drugs Market Overview 1.4 Features & Benefits of This Report 1.5 Methodology & Sources of Information 1.5.1 Research Methodology 1.5.2 Research Process 1.5.3 Base Year 1.5.4 Report Assumptions & Caveats 2 Global Brand Drugs Overall Market Size 2.1 Global Brand Drugs Market Size: 2023 VS 2030 2.2 Global Brand Drugs Market Size, Prospects & Forecasts: 2019-2030 2.3 Key Market Trends, Opportunity, Drivers and Restraints 2.3.1 Market Opportunities & Trends 2.3.2 Market Drivers 2.3.3 Market Restraints 3 Company Landscape 3.1 Top Brand Drugs Players in Global Market 3.2 Top Global Brand Drugs Companies Ranked by Revenue 3.3 Global Brand Drugs Revenue by Companies 3.4 Top 3 and Top 5 Brand Drugs Companies in Global Market, by Revenue in 2023 3.5 Global Companies Brand Drugs Product Type 3.6 Tier 1, Tier 2 and Tier 3 Brand Drugs Players in Global Market 3.6.1 List of Global Tier 1 Brand Drugs Companies 3.6.2 List of Global Tier 2 and Tier 3 Brand Drugs Companies 4 Market Sights by Product 4.1 Overview 4.1.1 By Type - Global Brand Drugs Market Size Markets, 2023 & 2030 4.1.2 Biopharmaceutical 4.1.3 Chemistry Medicine 4.2 By Type - Global Brand Drugs Revenue & Forecasts 4.2.1 By Type - Global Brand Drugs Revenue, 2019-2024 4.2.2 By Type - Global Brand Drugs Revenue, 2025-2030 4.2.3 By Type - Global Brand Drugs Revenue Market Share, 2019-2030 5 Sights by Application 5.1 Overview 5.1.1 By Application - Global Brand Drugs Market Size, 2023 & 2030 5.1.2 Hospital 5.1.3 Clinic 5.1.4 Other 5.2 By Application - Global Brand Drugs Revenue & Forecasts 5.2.1 By Application - Global Brand Drugs Revenue, 2019-2024 5.2.2 By Application - Global Brand Drugs Revenue, 2025-2030 5.2.3 By Application - Global Brand Drugs Revenue Market Share, 2019-2030 6 Sights by Region 6.1 By Region - Global Brand Drugs Market Size, 2023 & 2030 6.2 By Region - Global Brand Drugs Revenue & Forecasts 6.2.1 By Region - Global Brand Drugs Revenue, 2019-2024 6.2.2 By Region - Global Brand Drugs Revenue, 2025-2030 6.2.3 By Region - Global Brand Drugs Revenue Market Share, 2019-2030 6.3 North America 6.3.1 By Country - North America Brand Drugs Revenue, 2019-2030 6.3.2 US Brand Drugs Market Size, 2019-2030 6.3.3 Canada Brand Drugs Market Size, 2019-2030 6.3.4 Mexico Brand Drugs Market Size, 2019-2030 6.4 Europe 6.4.1 By Country - Europe Brand Drugs Revenue, 2019-2030 6.4.2 Germany Brand Drugs Market Size, 2019-2030 6.4.3 France Brand Drugs Market Size, 2019-2030 6.4.4 U.K. Brand Drugs Market Size, 2019-2030 6.4.5 Italy Brand Drugs Market Size, 2019-2030 6.4.6 Russia Brand Drugs Market Size, 2019-2030 6.4.7 Nordic Countries Brand Drugs Market Size, 2019-2030 6.4.8 Benelux Brand Drugs Market Size, 2019-2030 6.5 Asia 6.5.1 By Region - Asia Brand Drugs Revenue, 2019-2030 6.5.2 China Brand Drugs Market Size, 2019-2030 6.5.3 Japan Brand Drugs Market Size, 2019-2030 6.5.4 South Korea Brand Drugs Market Size, 2019-2030 6.5.5 Southeast Asia Brand Drugs Market Size, 2019-2030 6.5.6 India Brand Drugs Market Size, 2019-2030 6.6 South America 6.6.1 By Country - South America Brand Drugs Revenue, 2019-2030 6.6.2 Brazil Brand Drugs Market Size, 2019-2030 6.6.3 Argentina Brand Drugs Market Size, 2019-2030 6.7 Middle East & Africa 6.7.1 By Country - Middle East & Africa Brand Drugs Revenue, 2019-2030 6.7.2 Turkey Brand Drugs Market Size, 2019-2030 6.7.3 Israel Brand Drugs Market Size, 2019-2030 6.7.4 Saudi Arabia Brand Drugs Market Size, 2019-2030 6.7.5 UAE Brand Drugs Market Size, 2019-2030 7 Brand Drugs Companies Profiles 7.1 Pfizer 7.1.1 Pfizer Company Summary 7.1.2 Pfizer Business Overview 7.1.3 Pfizer Brand Drugs Major Product Offerings 7.1.4 Pfizer Brand Drugs Revenue in Global Market (2019-2024) 7.1.5 Pfizer Key News & Latest Developments 7.2 Roche 7.2.1 Roche Company Summary 7.2.2 Roche Business Overview 7.2.3 Roche Brand Drugs Major Product Offerings 7.2.4 Roche Brand Drugs Revenue in Global Market (2019-2024) 7.2.5 Roche Key News & Latest Developments 7.3 Sanofi 7.3.1 Sanofi Company Summary 7.3.2 Sanofi Business Overview 7.3.3 Sanofi Brand Drugs Major Product Offerings 7.3.4 Sanofi Brand Drugs Revenue in Global Market (2019-2024) 7.3.5 Sanofi Key News & Latest Developments 7.4 Johnson & Johnson 7.4.1 Johnson & Johnson Company Summary 7.4.2 Johnson & Johnson Business Overview 7.4.3 Johnson & Johnson Brand Drugs Major Product Offerings 7.4.4 Johnson & Johnson Brand Drugs Revenue in Global Market (2019-2024) 7.4.5 Johnson & Johnson Key News & Latest Developments 7.5 Merck & Co. (MSD) 7.5.1 Merck & Co. (MSD) Company Summary 7.5.2 Merck & Co. (MSD) Business Overview 7.5.3 Merck & Co. (MSD) Brand Drugs Major Product Offerings 7.5.4 Merck & Co. (MSD) Brand Drugs Revenue in Global Market (2019-2024) 7.5.5 Merck & Co. (MSD) Key News & Latest Developments 7.6 Novartis 7.6.1 Novartis Company Summary 7.6.2 Novartis Business Overview 7.6.3 Novartis Brand Drugs Major Product Offerings 7.6.4 Novartis Brand Drugs Revenue in Global Market (2019-2024) 7.6.5 Novartis Key News & Latest Developments 7.7 AbbVie 7.7.1 AbbVie Company Summary 7.7.2 AbbVie Business Overview 7.7.3 AbbVie Brand Drugs Major Product Offerings 7.7.4 AbbVie Brand Drugs Revenue in Global Market (2019-2024) 7.7.5 AbbVie Key News & Latest Developments 7.8 Gilead Sciences 7.8.1 Gilead Sciences Company Summary 7.8.2 Gilead Sciences Business Overview 7.8.3 Gilead Sciences Brand Drugs Major Product Offerings 7.8.4 Gilead Sciences Brand Drugs Revenue in Global Market (2019-2024) 7.8.5 Gilead Sciences Key News & Latest Developments 7.9 GlaxoSmithKline (GSK) 7.9.1 GlaxoSmithKline (GSK) Company Summary 7.9.2 GlaxoSmithKline (GSK) Business Overview 7.9.3 GlaxoSmithKline (GSK) Brand Drugs Major Product Offerings 7.9.4 GlaxoSmithKline (GSK) Brand Drugs Revenue in Global Market (2019-2024) 7.9.5 GlaxoSmithKline (GSK) Key News & Latest Developments 7.10 Amgen 7.10.1 Amgen Company Summary 7.10.2 Amgen Business Overview 7.10.3 Amgen Brand Drugs Major Product Offerings 7.10.4 Amgen Brand Drugs Revenue in Global Market (2019-2024) 7.10.5 Amgen Key News & Latest Developments 7.11 AstraZeneca 7.11.1 AstraZeneca Company Summary 7.11.2 AstraZeneca Business Overview 7.11.3 AstraZeneca Brand Drugs Major Product Offerings 7.11.4 AstraZeneca Brand Drugs Revenue in Global Market (2019-2024) 7.11.5 AstraZeneca Key News & Latest Developments 7.12 Bristol-Myers Squibb 7.12.1 Bristol-Myers Squibb Company Summary 7.12.2 Bristol-Myers Squibb Business Overview 7.12.3 Bristol-Myers Squibb Brand Drugs Major Product Offerings 7.12.4 Bristol-Myers Squibb Brand Drugs Revenue in Global Market (2019-2024) 7.12.5 Bristol-Myers Squibb Key News & Latest Developments 7.13 Eli Lilly 7.13.1 Eli Lilly Company Summary 7.13.2 Eli Lilly Business Overview 7.13.3 Eli Lilly Brand Drugs Major Product Offerings 7.13.4 Eli Lilly Brand Drugs Revenue in Global Market (2019-2024) 7.13.5 Eli Lilly Key News & Latest Developments 7.14 Teva 7.14.1 Teva Company Summary 7.14.2 Teva Business Overview 7.14.3 Teva Brand Drugs Major Product Offerings 7.14.4 Teva Brand Drugs Revenue in Global Market (2019-2024) 7.14.5 Teva Key News & Latest Developments 7.15 Bayer 7.15.1 Bayer Company Summary 7.15.2 Bayer Business Overview 7.15.3 Bayer Brand Drugs Major Product Offerings 7.15.4 Bayer Brand Drugs Revenue in Global Market (2019-2024) 7.15.5 Bayer Key News & Latest Developments 7.16 Novo Nordisk 7.16.1 Novo Nordisk Company Summary 7.16.2 Novo Nordisk Business Overview 7.16.3 Novo Nordisk Brand Drugs Major Product Offerings 7.16.4 Novo Nordisk Brand Drugs Revenue in Global Market (2019-2024) 7.16.5 Novo Nordisk Key News & Latest Developments 7.17 AbbVie 7.17.1 AbbVie Company Summary 7.17.2 AbbVie Business Overview 7.17.3 AbbVie Brand Drugs Major Product Offerings 7.17.4 AbbVie Brand Drugs Revenue in Global Market (2019-2024) 7.17.5 AbbVie Key News & Latest Developments 7.18 Takeda 7.18.1 Takeda Company Summary 7.18.2 Takeda Business Overview 7.18.3 Takeda Brand Drugs Major Product Offerings 7.18.4 Takeda Brand Drugs Revenue in Global Market (2019-2024) 7.18.5 Takeda Key News & Latest Developments 7.19 Boehringer Ingelheim 7.19.1 Boehringer Ingelheim Company Summary 7.19.2 Boehringer Ingelheim Business Overview 7.19.3 Boehringer Ingelheim Brand Drugs Major Product Offerings 7.19.4 Boehringer Ingelheim Brand Drugs Revenue in Global Market (2019-2024) 7.19.5 Boehringer Ingelheim Key News & Latest Developments 7.20 Takeda 7.20.1 Takeda Company Summary 7.20.2 Takeda Business Overview 7.20.3 Takeda Brand Drugs Major Product Offerings 7.20.4 Takeda Brand Drugs Revenue in Global Market (2019-2024) 7.20.5 Takeda Key News & Latest Developments 8 Conclusion 9 Appendix 9.1 Note 9.2 Examples of Clients 9.3 Disclaimer -
Inquiry Before Buying
WHY CHOOSE US
Discover Business Growth OpportunitiesMore than 10 Years Experience Employee SupportIn-depth and Comprehensive Analysis100+ Client Queries Handled Everyday -
Request Sample
WHY CHOOSE US
Easy Access and Express Report Delivery ServiceDiscover Business Growth OpportunitiesMore than 10 Years Experience Employee SupportIn-depth and Comprehensive Analysis100+ Client Queries Handled Everyday
